NGS applied to unravel ovarian cancer gene mutations

NGS applied to unravel ovarian cancer gene mutations

Sergio Marchini and Luca Beltrame, IRCCS “Mario Negri” Institute for Pharmacological Research, Milan, Italy
Topic: Cancer Genomics : Sequencing : Customer

Watch the webinar presented by Italian cancer researchers Sergio Marchini and Luca Beltrame from the IRCCS “Mario Negri” Institute for Pharmacological Research in Milan. Using next-generation sequencing, their team carried out a retrospective study to investigate the mutational profile of ovarian cancer genes involved in pathways related to drug sensitivity in a cohort of solid tumors.

The team will discuss their results, recently published in Annals of Oncology, and the potential impact of genetic analysis to ultimately improve the clinical management of cancer therapies in the future.



There are no related events.